Mitogen- and stress-activated protein kinase 1 MSK1 regulates glucocorticoid response element promoter activity in a

Ilse M Beck1, Dorien Clarisse, Nadia Bougarne

  • 1Laboratory of Experimental Cancer Research, Department of Radiation Therapy & Experimental Cancer Research, Ghent University, UZ 1P7, De Pintelaan 185, B-9000 Gent, Belgium. Ilse.Beck@UGent.be

Insights

Mitogen- and stress-activated protein kinase (MSK1) impacts glucocorticoid receptor (GR) activity. MSK1 or MAPK inhibition affects GR transactivation differently based on GR activation levels, suggesting complex roles in anti-inflammatory therapies.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Pharmacology

Background:

  • The glucocorticoid receptor (GR) is a key regulator of cellular responses, often acting through anti-inflammatory mechanisms.
  • Mitogen- and stress-activated protein kinase 1 (MSK1) is involved in chromatin remodeling and stress responses.
  • GR can target MSK1 for anti-inflammatory effects, but the converse interaction is less understood.

Purpose of the Study:

  • To investigate the impact of MSK1 and its upstream kinases on GR-mediated transactivation.
  • To explore the concentration-dependent effects of MSK1 and MAPK inhibition on GR activity.
  • To elucidate the role of MSK1 in GR's nucleocytoplasmic translocation.

Main Methods:

  • Utilized reporter gene assays to measure GRE-regulated promoter activity.
  • Employed kinase inhibitors (H89, SB203580, U0126) to modulate MSK1 and MAPK activity.
  • Assessed glucocorticoid-induced nucleocytoplasmic translocation of MSK1.

Main Results:

  • MSK1-activating kinases enhanced GRE-regulated promoter activity in a concentration-dependent manner.
  • Inhibition of MSK1 or MAPKs diminished maximal GR-mediated activity but enhanced sub-maximal activity.
  • Glucocorticoid-induced MSK1 translocation into the nucleus was concentration-dependent.

Conclusions:

  • MSK1 and MAPK activity exert complex, concentration-dependent effects on GR transactivation.
  • The findings reveal a nuanced interplay between kinase signaling and GR function.
  • Further research is needed to explore combined glucocorticoid and kinase inhibitor strategies for anti-inflammatory applications.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...